UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1013-1013

2016

Volltextzugriff (PDF)

Trastuzumab (T) and everolimus (E) pharmacokinetics (PK) in HER2 positive (+) primary breast cancer (BC) patients (pts): Unicancer RADHER trial results

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2599-2599

2013

Volltextzugriff (PDF)

BOLERO-4: Multicenter, open-label, phase II study of everolimus plus letrozole as first-line therapy in ER + , HER2 - metastatic breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS661-TPS661

2013

Volltextzugriff (PDF)

Comparative efficacy of everolimus versus fulvestrant for hormone-receptor–positive (HR + ) advanced breast cancer (ABC) following progression/recurrence after first-line treatment: A network meta-analysis

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e11602-e11602

2013

Volltextzugriff (PDF)

Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.501-501

2014

Volltextzugriff (PDF)

First-line pertuzumab (P), trastuzumab (H), and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC): Interim safety results (N=704) from PERUSE

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.548-548

2014

Volltextzugriff (PDF)

Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.1013-1013

2014

Volltextzugriff (PDF)

Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib + paclitaxel vs trastuzumab + paclitaxel as first-line treatment for HER2+ metastatic breast cancer (NEfERTT)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.610-610

2015

Volltextzugriff (PDF)

ELYPSE-7: A randomized, placebo-controlled, phase 2a study evaluating the impact of IL-7 on CD4 count, hematological toxicity, and tumor progressionin metastatic breast cancer (MBC) patients (pts)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3033-3033

2014

Volltextzugriff (PDF)

Array CGH and DNA sequencing to personalize targeted treatment of metastatic breast cancer (MBC) patients (pts): A prospective multicentric trial (SAFIR01)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.511-511

2013

Volltextzugriff (PDF)

Incidence, management, and resolution of noninfectious pneumonitis in BOLERO-2

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.561-561

2013

Volltextzugriff (PDF)

Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.557-557

2013

Volltextzugriff (PDF)

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1137-1149

1994

Volltextzugriff (PDF)

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

Journal of clinical oncology, 1992-10, Vol.10 (10), p.1579-1591

1992

Volltextzugriff (PDF)

Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions

Journal of periodontology (1970), 2018-06, Vol.89 (S1), p.S173-S182

2018

Volltextzugriff (PDF)

Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information

PLoS biology, 2017-01, Vol.15 (1), p.e2001402

2017

Volltextzugriff (PDF)

Y recombination arrest and degeneration in the absence of sexual dimorphism

Science (American Association for the Advancement of Science), 2022-02, Vol.375 (6581), p.663-666

2022

Volltextzugriff (PDF)

Triplet state CPL active helicene-dithiolene platinum bipyridine complexes

Chemical communications (Cambridge, England), 2017-08, Vol.53 (66), p.9210-9213

2017

Volltextzugriff (PDF)

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

Critical care (London, England), 2022-01, Vol.26 (1), p.30-11, Article 30

2022

Volltextzugriff (PDF)

Victorian Studies Alumni Conference, Indiana University, Bloomington

Victorian Studies, 1985, Vol.28 (2), p.305-308

1985

Volltextzugriff (PDF)

Resilience after trauma: The role of memory suppression

Science (American Association for the Advancement of Science), 2020-02, Vol.367 (6479)

2020

Volltextzugriff (PDF)

Optimal metrology with programmable quantum sensors

Nature (London), 2022-03, Vol.603 (7902), p.604-609

2022

Volltextzugriff (PDF)

Efficient and stable perovskite-silicon tandem solar cells through contact displacement by MgFx

Science (American Association for the Advancement of Science), 2022-07, Vol.377 (6603), p.302-306

2022

Volltextzugriff (PDF)

26 – 50 von 1.214

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBiology Of Blood And Marrow Transplantation

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.171)
Mit Volltextzugriff
(952)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(744)
Life Sciences & Biomedicine
(572)
Humans
(459)
Male
(257)
Female
(244)
Middle Aged
(174)
Adult
(156)
Biological And Medical Sciences
(155)
Aged
(144)
Animals
(142)
Life Sciences
(138)
Medical Sciences
(134)
Science & Technology - Other Topics
(91)
Multidisciplinary Sciences
(90)
Physical Sciences
(83)
Surgery
(82)
General & Internal Medicine
(75)
Mice
(75)
Biochemistry & Molecular Biology
(65)
Treatment Outcome
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study

Trastuzumab (T) and everolimus (E) pharmacokinetics (PK) in HER2 positive (+) primary breast cancer (BC) patients (pts): Unicancer RADHER trial results

BOLERO-4: Multicenter, open-label, phase II study of everolimus plus letrozole as first-line therapy in ER + , HER2 - metastatic breast cancer

Comparative efficacy of everolimus versus fulvestrant for hormone-receptor–positive (HR + ) advanced breast cancer (ABC) following progression/recurrence after first-line treatment: A network meta-analysis

Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study

First-line pertuzumab (P), trastuzumab (H), and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC): Interim safety results (N=704) from PERUSE

Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine

Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib + paclitaxel vs trastuzumab + paclitaxel as first-line treatment for HER2+ metastatic breast cancer (NEfERTT)

ELYPSE-7: A randomized, placebo-controlled, phase 2a study evaluating the impact of IL-7 on CD4 count, hematological toxicity, and tumor progressionin metastatic breast cancer (MBC) patients (pts)

AVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+ BC) stratified according to PET change after one therapy cycle

Array CGH and DNA sequencing to personalize targeted treatment of metastatic breast cancer (MBC) patients (pts): A prospective multicentric trial (SAFIR01)

Incidence, management, and resolution of noninfectious pneumonitis in BOLERO-2

Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions

Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information

Y recombination arrest and degeneration in the absence of sexual dimorphism

Triplet state CPL active helicene-dithiolene platinum bipyridine complexes

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

Victorian Studies Alumni Conference, Indiana University, Bloomington

Resilience after trauma: The role of memory suppression

Optimal metrology with programmable quantum sensors

Efficient and stable perovskite-silicon tandem solar cells through contact displacement by MgFx

Aktive Filter

Suchergebnisse filtern